P2X7 receptor-stimulation causes fever via PGE2 and IL-1β release

FASEB J. 2012 Jul;26(7):2951-62. doi: 10.1096/fj.12-205765. Epub 2012 Apr 6.

Abstract

Prostaglandins (PGs) are important lipid mediators involved in the development of inflammatory associated pain and fever. PGE2 is a well-established endogenous pyrogen activated by proinflammatory cytokine interleukin (IL)-1β. P2X7 receptors (P2X7Rs) expressed by inflammatory cells are stimulated by the danger signal extracellular ATP to activate the inflammasome and release IL-1β. Here we show that P2X7R activation is required for the release of PGE2 and other autacoids independent of inflammasome activation, with an ATP EC(50) for PGE2 and IL-1β release of 1.58 and 1.23 mM, respectively. Furthermore, lack of P2X7R or specific antagonism of P2X7R decreased the febrile response in mice triggered after intraperitoneal LPS or IL-1β inoculation. Accordingly, LPS inoculation caused intraperitoneal ATP accumulation. Therefore, P2X7R antagonists emerge as novel therapeutics for the treatment for acute inflammation, pain and fever, with wider anti-inflammatory activity than currently used cyclooxygenase inhibitors.-Barberà-Cremades, M., Baroja-Mazo, A., Gomez, A. I., Machado, F., Di Virgilio, F., Pelegrín, P. P2X7 receptor-stimulation causes fever via PGE2 and IL-1β release.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / administration & dosage
  • Adenosine Triphosphate / metabolism
  • Animals
  • Calcium Signaling
  • Cyclooxygenase 2 / metabolism
  • Dinoprostone / physiology*
  • Fever / etiology*
  • Fever / physiopathology*
  • Humans
  • In Vitro Techniques
  • Inflammation Mediators / physiology
  • Injections, Intraperitoneal
  • Interleukin-1beta / administration & dosage
  • Interleukin-1beta / physiology*
  • Leukotriene B4 / biosynthesis
  • Lipopolysaccharides / administration & dosage
  • MAP Kinase Signaling System
  • Macrophages / drug effects
  • Macrophages / physiology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Purinergic P2X Receptor Agonists / pharmacology
  • Purinergic P2X Receptor Antagonists / pharmacology
  • Receptors, Purinergic P2X4 / physiology
  • Receptors, Purinergic P2X7 / deficiency
  • Receptors, Purinergic P2X7 / genetics
  • Receptors, Purinergic P2X7 / physiology*
  • Recombinant Proteins / administration & dosage
  • Thromboxane B2 / biosynthesis

Substances

  • Inflammation Mediators
  • Interleukin-1beta
  • Lipopolysaccharides
  • Purinergic P2X Receptor Agonists
  • Purinergic P2X Receptor Antagonists
  • Receptors, Purinergic P2X4
  • Receptors, Purinergic P2X7
  • Recombinant Proteins
  • Leukotriene B4
  • Thromboxane B2
  • Adenosine Triphosphate
  • Cyclooxygenase 2
  • Dinoprostone